We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Innovative Implant Treats Lumbar Spinal Stenosis

By HospiMedica International staff writers
Posted on 18 Sep 2018
A non-fusion, motion-preserving implant used following decompression procedures helps stabilize the lumbar spine without resorting to fusion.

The Paradigm Spine (New York, NY, USA) coflex device is a small, U-shaped interlaminar titanium stabilization device indicated for use after a spinal decompression procedure on one or two level contiguous lumbar motion segments (L1-L5) in skeletally mature patients, with at least moderate impairment in function, who experience relief during flexion from leg, buttocks, or/and groin pain (with or without back pain), and who previously underwent at least six months of non-operative treatment. The device is implanted midline between adjacent lamina, and is available in five different anatomical sizes.

During the clinical procedure, the “U” is positioned horizontally, with the apex oriented anteriorly and the two long side arms paralleling the long axis of the spinous processes. The bone-facing surfaces are ridged to provide resistance to migration. Features include a biocompatible and x-ray visible titanium composition; crimped wings for increased primary stability; a center of rotation close to the spinal canal to provide increased rotational stability; stress reduction on facet joints; a large contact area for optimized stress distribution; protection of posterior elements; and maintenance of foraminal height.

“There is now potentially a more effective surgical option between the two typical treatments for lumbar spinal stenosis, and we are proud to lead the way in changing the standard of care for surgeons and their patients with this diagnosis,” said Marc Viscogliosi, chairman and CEO of Paradigm Spine. “Paradigm Spine has worked diligently to build the pieces of the puzzle in establishing coflex as the new standard of care for the treatment of moderate to severe lumbar spinal stenosis.”

Lumbar spinal stenosis is a debilitating and degenerative disease in older patients, often associated with significant leg and back pain, leg numbness, and weakness, which causes a significant reduction activity. Decompression alone is effective at relieving pain symptoms caused by lumbar spinal stenosis, but long term symptomatic relief is elusive, often resulting in subsequent opioid pain control, epidural injections for pain management, or additional surgeries for conversion to a fusion. Decompression with fusion has proven to provide pain relief and stabilize the diseased segment, but may lead to adjacent level disease requiring subsequent surgeries.

Related Links:
Paradigm Spine


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
New
Double Door Pharmacy Refrigerator
iPR256-GX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel approach utilizes continuous glucose monitoring to detect early signs of impaired glucose regulation (Photo courtesy of Shinya Kuroda/University of Tokyo)

Wearable Glucose Monitor Offers Less Invasive Approach to Assessing Diabetes Risk

Diabetes, often referred to as a "silent epidemic," is a growing global health issue with significant impacts on both health and the economy. Detecting impaired glucose regulation early — an intermediate... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.